Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
 3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Operating Activities:    
Net Loss $ (1,278,922) $ (796,534)
Adjustments to reconcile net loss from operations to net cash used in operating activities:    
Stock-based compensation 147,163 350,745
Depreciation and amortization 6,119 6,166
Unrealized (gains) loss on marketable securities 3,359 (87,929)
Changes in non-cash operating working capital items:    
Accounts receivable - fees and reimbursable project costs 183,690 (648,043)
Prepaid expenses and other assets (131,779) (67,901)
Accounts payable, accrued liabilities and other current liabilities 8,396 (268,122)
Net Cash Used In Operating Activities (1,061,974) (1,511,618)
Investing Activities:    
Purchase of Marketable securities (17,866) (63,010)
Patent costs (34,357) (28,029)
Net Cash Used In Investing Activities (52,223) (91,039)
Financing Activities:    
Restricted cash (410) (549)
Net Cash Used In Financing Activities (410) (549)
Net Decrease In Cash and Cash Equivalents (1,114,607) (1,603,206)
Cash and Cash Equivalents, Beginning of Period 2,197,555 3,569,098
Cash and Cash Equivalents, End of Period 1,082,948 1,965,892
Cash paid during the year:    
Interest paid 0 0
Income taxes paid $ 0 $ 0